...
机译:由B16F10癌症干细胞疫苗介导的黑色素瘤的有效肿瘤免疫
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Gynecology &
Obstetrics Zhongda Hospital School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Department of Pathogenic Biology and Immunology School of Medicine Southeast University;
Melanoma; Cancer stem cells; Cancer stem cell vaccine; New York esophageal squamous cell carcinoma-1;
机译:由B16F10癌症干细胞疫苗介导的黑色素瘤的有效肿瘤免疫
机译:通过增加CD8(+)T细胞的渗透并改变小鼠B16F10黑素瘤异种移植物,通过增加渗透抗肿瘤免疫效果来改善抗肿瘤免疫效应
机译:肿瘤裂解物是一种有效的疫苗抗原,可刺激CD4(+)T细胞功能并随后诱导CD8(+)T细胞介导的抗肿瘤免疫力
机译:肝素基IL-12复合凝聚层抑制B16F10黑色素瘤肿瘤进展。
机译:使用HER-2 / neu基因的腺病毒介导表达和表达热休克蛋白70的凋亡肿瘤细胞的基于树突细胞的癌症疫苗。
机译:在B16F10小鼠黑素瘤模型中抗IL-10介导的靶向树突状细胞的MIP3α-gp100疫苗的抗肿瘤功效增强取决于I型干扰素。
机译:通过增加CD8 + T细胞的渗透并改变鼠B16F10黑素瘤异种移植物的肿瘤血管来改善抗肿瘤免疫效果